Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
EV to Sales History
Trending lower.
Left:
||||
Enterprise value to sales ratio
Latest
228.31
Near historical average
Average (9y)
213.78
Historical baseline
Range
High:875.86
Low:1.21
CAGR
-1.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 228.31 | -16.8% |
| 2023 | 274.48 | -68.7% |
| 2022 | 875.86 | +151.4% |
| 2021 | 348.40 | +439.6% |
| 2020 | 64.56 | +831.1% |
| 2019 | 6.93 | +473.0% |
| 2018 | 1.21 | -95.3% |
| 2017 | 26.00 | -44.3% |
| 2016 | 46.71 | -82.4% |
| 2015 | 265.34 | - |